Explore how an innovative medicine moves from approval to patient access.
Selected market
Ireland
After authorisation, NCPE rapid review determines whether a full HTA is needed. HSE then separates assessment, commercial negotiation, statutory/executive funding approval and scheme or hospital implementation.
EMA/EC or HPRA
manufacturer / HSE CPU
NCPE
NCPE / applicant / clinicians/patients
HSE CPU / company
8 decision nodes12 cited sources
For education only — not regulatory, pricing or legal advice.
